STANDARD GLUCO NAVII
LIVE

Serial Number

97630309

Owner

SD BIOSENSOR, INC.

Attorney

Brian P. Gregg

Filing Date

Oct 13, 2022

Add to watchlist:

No watchlists yet
View on USPTO

STANDARD GLUCO NAVII Trademark

Serial Number: 97630309 • Registration: 7787782

STANDARD GLUCO NAVII is a trademark filed by SD BIOSENSOR, INC. on October 13, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

SD BIOSENSOR, INC. (26 trademarks)

C-4th & 5th, 16, Deogyeong-daero
Gyeonggi-do, 16690 , KR

Entity Type: 11

Trademark Details

Filing Date

October 13, 2022

Registration Date

May 6, 2025

Published for Opposition

October 17, 2023

Goods & Services

Diagnostic preparations for medical use for diagnosing tuberculosis; diagnostic chemical preparations for medical use for the diagnosis of diabetes; diagnostic reagents for immunization disease for medical or veterinary use; medical diagnostic agents for pharmaceutical use; diagnostic preparations for medical or veterinary purposes; diagnostic reagents for medical or veterinary purposes; reagents and media for medical and veterinary diagnostic purposes; diagnostic preparations for medical and veterinary use; medical diagnostic test strips for testing and analysis of body fluids; medical diagnostic reagents for use in diagnostic tests for medical purposes; medical diagnostic reagents; diagnostic preparations for medical purposes; diagnostic chemical reagents for medical use; in vitro diagnostic preparations for medical purposes; medical diagnostic reactants for medical diagnosis; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for diagnosis, namely, pharmaceutical diagnostic preparations for medical purposes

Indicators for medical diagnosis, namely, glucose meters; diagnostic medical apparatus for automatic diagnosis of tuberculosis; diagnostic measuring apparatus for medical use for the analysis of body fluids; diagnostic testing instruments for use in medical immunoassay procedure, namely, medical diagnostic apparatus for measuring blood glucose levels; apparatus for carrying-out diagnostic tests for medical purposes, namely, medical diagnostic apparatus for measuring blood glucose levels; diagnostic apparatus for medical purposes, namely, medical diagnostic apparatus for measuring blood glucose levels; medical apparatus and instruments in the fields of clinical diagnosis, namely, medical diagnostic apparatus for measuring blood glucose levels; diagnostic, examination, and monitoring equipment, namely, medical diagnostic apparatus for the measurement of blood glucose levels, patient monitoring sensors; testing instruments for medical diagnostic purposes, namely, blood testing apparatus; tools for medical diagnostics, namely, probes for medical purposes; sensor apparatus for medical use in diagnosis, namely, medical products in the nature of biofeedback sensors, electrochemical sensors for determination of analyte concentrations in fluids for medical purposes; testing probes for medical diagnostic purposes; medical diagnostic apparatus for medical purposes, namely, medical diagnostic apparatus for measuring blood glucose levels; in vitro diagnostic devices for medical purposes, namely, in vitro medical diagnostic apparatus for measuring blood glucose levels

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 6, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
May 6, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 11, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 11, 2025 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 8, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 8, 2025 CRFA
ASSIGNED TO LIE
Apr 8, 2025 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 26, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 28, 2025 GNRN
NON-FINAL ACTION E-MAILED
Feb 28, 2025 GNRT
SU - NON-FINAL ACTION - WRITTEN
Feb 28, 2025 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Feb 13, 2025 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 13, 2025 AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 13, 2025 AITU
USE AMENDMENT FILED
Dec 3, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Dec 3, 2024 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 27, 2024 EXRA
SOU EXTENSION 1 GRANTED
Apr 26, 2024 EX1G
SOU EXTENSION 1 FILED
Apr 26, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 26, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 12, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 17, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 17, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 27, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 11, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 11, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 11, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 11, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 11, 2023 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 7, 2023 GNFN
FINAL REFUSAL E-MAILED
Sep 7, 2023 GNFR
FINAL REFUSAL WRITTEN
Sep 7, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 6, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 6, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 6, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 22, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 22, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jun 22, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 20, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 27, 2022 NWOS
NEW APPLICATION ENTERED
Oct 17, 2022 NWAP